Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Substrate-selective positive allosteric modulation of PTPRD’s phosphatase by flavonols

Biochemical Pharmacology(2022)10.1016/j.bcp.2022.115109Source: DataRank Database

Substrate-selective positive allosteric modulation of PTPRD’s phosphatase by flavonols is a research paper published in Biochemical Pharmacology (2022). On theSindex it has a DataRank of 0.360. It has been cited 10 times.

N/A

0.360DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.55)OA: greenTopics (53)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.360

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Carlissa Marez,Karol Dokładny ORCID,Jane Smoake,María Jimena Martínez ORCID,David K. Johnson ORCID

Live enrichment

PubMed:35636503 OpenAlex:https://openalex.org/W4281641505

National Institute on Aging

Grant: U01DA047713

National Institutes of Health

Grant: 5U01DA047713-03

PTPRD ligands for stimulant and opiate use disorders

NIDA NIH HHS

Grant: UG3 DA056039

FWCI

0.55

Citation Percentile

0.6%

Citation Trend

2023

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10184881/pdf/nihms-1815891.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0006295222002039?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006295222002039?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10184881

Fields of Study

Protein Tyrosine PhosphatasesGenomics, phytochemicals, and oxidative stressNatural product bioactivities and synthesis0301 basic medicine0303 health sciences03 medical and health sciencesAlzheimer DiseaseAnimalsFlavonolsGlycogen Synthase Kinase 3HumansNeurofibrillary TanglesPhosphoric Monoester HydrolasesPhosphorylationReceptor-Like Protein Tyrosine Phosphatases, Class 2tau Proteins

MeSH Terms

Alzheimer DiseaseAnimalsHumansPhosphoric Monoester HydrolasesPhosphorylationNeurofibrillary Tanglestau ProteinsGlycogen Synthase Kinase 3FlavonolsReceptor-Like Protein Tyrosine Phosphatases, Class 2

Keywords

DephosphorylationPhosphataseAllosteric regulationProtein tyrosine phosphatasePhosphorylationCell biologyKinaseProtein phosphatase 2ChemistryBiologyBiochemistryCancer researchEnzymeFlavonolsReceptor-Like Protein Tyrosine Phosphatases, Class 2Neurofibrillary Tanglestau ProteinsPhosphoric Monoester HydrolasesGlycogen Synthase Kinase 3Alzheimer DiseaseAnimalsHumansAlzheimer’s diseaseNeurodegenerationQuercetinReceptor type protein tyrosine phosphataseTauopathy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being